Kazia Therapeutics closes $40 million offering with potential proceeds of $120 million
AI Summary- Kazia Therapeutics closed its oversubscribed registered public offering.
- The financing generated approximately $40 million upfront and could add $80 million.
- Kazia will host a corporate update call on September 1, 2026.